London-based LabGenius, which uses ML to find and design antibody therapies to treat cancer, raised a £35M Series B led by Merck’s VC arm, M Ventures (Mimi Billing/Sifted)

Mimi Billing / Sifted:
London-based LabGenius, which uses ML to find and design antibody therapies to treat cancer, raised a £35M Series B led by Merck's VC arm, M Ventures  —  It's robotic platform is using machine learning to create new molecules to tackle cancer  —  UK drug discovery startup LabGenius …